Publications

Cancer gene therapy

Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells.

01-04-2024

Cellular & molecular immunology

CD4⁺ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors.

01-04-2024

JAMA network open

Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.

01-04-2024

Life science alliance

Variety in the USP deubiquitinase catalytic mechanism.

01-04-2024

Annals of oncology : official journal of the European Society for Medical Oncology

Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey.

01-04-2024

Molecular pharmaceutics

Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice.

01-04-2024

Clinical cancer research : an official journal of the American Association for Cancer Research

Combining Genomic Biomarkers to Guide Immunotherapy in Non-Small Cell Lung Cancer.

01-04-2024

European journal of cancer (Oxford, England : 1990)

Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma.

01-04-2024

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Redispensing of expensive oral anticancer medicines: A practical application.

01-04-2024

Nature

Publisher Correction: Decoding chromatin states by proteomic profiling of nucleosome readers.

01-04-2024

Physics and imaging in radiation oncology

Interobserver variation in tumor delineation of liver metastases using Magnetic Resonance Imaging.

01-04-2024

Protein science : a publication of the Protein Society

Conserved proline residues prevent dimerization and aggregation in the β-lactamase BlaC.

01-04-2024

Breast (Edinburgh, Scotland)

Seizing the moment: The time for harnessing electronic patient-reported outcome measures for enhanced and sustainable metastatic breast cancer care is now.

01-04-2024

Journal of biomedical optics

Margin assessment during breast conserving surgery using diffuse reflectance spectroscopy.

01-04-2024

Magnetic resonance imaging

On retrospective k-space subsampling schemes for deep MRI reconstruction.

01-04-2024

Pharmaceutical research

Pharmacokinetics of PEGasparaginase in Infants with Acute Lymphoblastic Leukemia.

01-04-2024

Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society

Dynamic recurrent inference machines for accelerated MRI-guided radiotherapy of the liver.

01-04-2024

Medicine and science in sports and exercise

Determinants of Physical Activity among Patients with Colorectal Cancer: From Diagnosis to 5 Years after Diagnosis.

01-04-2024

Journal of cancer survivorship : research and practice

Correction to: Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire.

01-04-2024

Cancer chemotherapy and pharmacology

Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients.

01-04-2024

Journal of cancer survivorship : research and practice

Neuropsychological test performance and self-reported cognitive functioning associated with work-related outcomes in occupationally active cancer survivors with cognitive complaints.

01-04-2024

FEBS letters

EU-LIFE charter of independent life science research institutes.

01-04-2024

Clinical genitourinary cancer

Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy.

01-04-2024

Toxicology and applied pharmacology

The ABCB1 and ABCG2 efflux transporters limit brain disposition of the SYK inhibitors entospletinib and lanraplenib.

01-04-2024

European journal of radiology

Artificial intelligence and explanation: How, why, and when to explain black boxes.

01-04-2024

ESMO open

Elements of successful patient involvement in clinical cancer trials: a review of the literature.

01-04-2024

Physics and imaging in radiation oncology

A deep learning based dynamic arc radiotherapy photon dose engine trained on Monte Carlo dose distributions.

01-04-2024

Cell

Generating and using real-world data: A worthwhile uphill battle.

28-03-2024

Communications biology

GFI1B and LSD1 repress myeloid traits during megakaryocyte differentiation.

28-03-2024

Cell

Embracing cancer complexity: Hallmarks of systemic disease.

28-03-2024

Journal for immunotherapy of cancer

Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial.

26-03-2024

Health and quality of life outcomes

Acceptability and usefulness of the EORTC 'Write In three Symptoms/Problems' (WISP): a brief open-ended instrument for symptom assessment in cancer patients.

26-03-2024

Cancer journal (Sudbury, Mass.)

Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma.

25-03-2024

Nature communications

Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma.

22-03-2024

Molecular cell

Transcription factor exchange enables prolonged transcriptional bursts.

21-03-2024

Nature communications

Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors.

21-03-2024

Molecular cell

Visualization of translation reorganization upon persistent ribosome collision stress in mammalian cells.

21-03-2024

medRxiv : the preprint server for health sciences

Risk factors for breast cancer subtypes by race and ethnicity: A scoping review of the literature.

19-03-2024

Cell reports. Medicine

Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse.

19-03-2024

Cancer cell

Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer.

11-03-2024

The New England journal of medicine

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.

07-03-2024

Molecular cell

Plot twists and cutting corners with atypical SMCs.

07-03-2024

Investigative radiology

Artificial Intelligence-Enhanced Breast MRI: Applications in Breast Cancer Primary Treatment Response Assessment and Prediction.

01-03-2024

European journal of cancer (Oxford, England : 1990)

The side effect registry immuno-oncology (SERIO) - A tool for systematic analysis of immunotherapy-induced side effects.

01-03-2024

The journal of pathology. Clinical research

Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite-instable colorectal cancers.

01-03-2024

Nature reviews. Clinical oncology

Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma.

01-03-2024

The EMBO journal

PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair.

01-03-2024

EClinicalMedicine

Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021.

01-03-2024

European urology

Management of Lymph Node-positive Penile Cancer: A Systematic Review.

01-03-2024

Nature

Decoding chromatin states by proteomic profiling of nucleosome readers.

01-03-2024

Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells.

CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors.

Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.

Variety in the USP deubiquitinase catalytic mechanism.

Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey.

Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice.

Combining Genomic Biomarkers to Guide Immunotherapy in Non-Small Cell Lung Cancer.

Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma.

Redispensing of expensive oral anticancer medicines: A practical application.

Publisher Correction: Decoding chromatin states by proteomic profiling of nucleosome readers.

Interobserver variation in tumor delineation of liver metastases using Magnetic Resonance Imaging.

Conserved proline residues prevent dimerization and aggregation in the β-lactamase BlaC.

Seizing the moment: The time for harnessing electronic patient-reported outcome measures for enhanced and sustainable metastatic breast cancer care is now.

Margin assessment during breast conserving surgery using diffuse reflectance spectroscopy.

On retrospective k-space subsampling schemes for deep MRI reconstruction.

Pharmacokinetics of PEGasparaginase in Infants with Acute Lymphoblastic Leukemia.

Dynamic recurrent inference machines for accelerated MRI-guided radiotherapy of the liver.

Determinants of Physical Activity among Patients with Colorectal Cancer: From Diagnosis to 5 Years after Diagnosis.

Correction to: Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire.

Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients.

Neuropsychological test performance and self-reported cognitive functioning associated with work-related outcomes in occupationally active cancer survivors with cognitive complaints.

EU-LIFE charter of independent life science research institutes.

Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy.

The ABCB1 and ABCG2 efflux transporters limit brain disposition of the SYK inhibitors entospletinib and lanraplenib.

Artificial intelligence and explanation: How, why, and when to explain black boxes.

Elements of successful patient involvement in clinical cancer trials: a review of the literature.

A deep learning based dynamic arc radiotherapy photon dose engine trained on Monte Carlo dose distributions.

Generating and using real-world data: A worthwhile uphill battle.

GFI1B and LSD1 repress myeloid traits during megakaryocyte differentiation.

Embracing cancer complexity: Hallmarks of systemic disease.

Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial.

Acceptability and usefulness of the EORTC 'Write In three Symptoms/Problems' (WISP): a brief open-ended instrument for symptom assessment in cancer patients.

Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma.

Cancer cell genetics shaping of the tumor microenvironment reveals myeloid cell-centric exploitable vulnerabilities in hepatocellular carcinoma.

Transcription factor exchange enables prolonged transcriptional bursts.

Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors.

Visualization of translation reorganization upon persistent ribosome collision stress in mammalian cells.

Risk factors for breast cancer subtypes by race and ethnicity: A scoping review of the literature.

Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse.

Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer.

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.

Plot twists and cutting corners with atypical SMCs.

Artificial Intelligence-Enhanced Breast MRI: Applications in Breast Cancer Primary Treatment Response Assessment and Prediction.

The side effect registry immuno-oncology (SERIO) - A tool for systematic analysis of immunotherapy-induced side effects.

Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite-instable colorectal cancers.

Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma.

PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair.

Improving survival in advanced melanoma patients: a trend analysis from 2013 to 2021.

Management of Lymph Node-positive Penile Cancer: A Systematic Review.

Decoding chromatin states by proteomic profiling of nucleosome readers.

This site uses cookies

CD4⁺ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors.